Found: 153
Select item for more details and to access through your institution.
Dermatologic events from EGFR inhibitors: the issue of the missing patient voice.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Mechanisms of skin aging induced by EGFR inhibitors.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Xerosis and pruritus as major EGFRI-associated adverse events.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Oral minoxidil for late alopecia in cancer survivors.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 208, n. 3, p. 491, doi. 10.1007/s10549-024-07440-5
- By:
- Publication type:
- Article
Predictors of immediate and delayed cutaneous hypersensitivity reactions to paclitaxel.
- Published in:
- Archives of Dermatological Research, 2024, v. 316, n. 9, p. 1, doi. 10.1007/s00403-024-03402-5
- By:
- Publication type:
- Article
A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013.
- Published in:
- Journal of Patient-Reported Outcomes, 2020, v. 4, n. 1, p. 1, doi. 10.1186/s41687-020-00220-x
- By:
- Publication type:
- Article
Dermatologic Adverse Events Associated With Use of Adjuvant Lapatinib in Combination With Paclitaxel and Trastuzumab for HER2-Positive Breast Cancer: A Case Series Analysis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A Pilot Study of Dose-Dense Paclitaxel With Trastuzumab and Lapatinib for Node-negative HER2-Overexpressed Breast Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Assessment and Treatment Outcomes of Persistent Radiation-Induced Alopecia in Patients With Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clinical Characterization of Immunotherapy-Related Pruritus Among Patients Seen in 2 Oncodermatology Clinics.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Endocrine Therapy-Induced Alopecia in Patients With Breast Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Eruptive Keratoacanthomas Associated With Pembrolizumab Therapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Increased Airport Scrutiny by the Transportation Security Administration of a Patient-Passenger Carrying Ammonium Lactate-Containing Moisturizer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Differential Radiation Dermatitis in Native Skin and an Autologous Transplanted Myocutaneous Flap.
- Published in:
- JAMA Dermatology, 2014, v. 150, n. 12, p. 1365, doi. 10.1001/jamadermatol.2014.888
- By:
- Publication type:
- Article
Overview Photography and Short-term Mole Monitoring in Patients Taking a BRAF Inhibitor.
- Published in:
- JAMA Dermatology, 2014, v. 150, n. 9, p. 1010, doi. 10.1001/jamadermatol.2013.10413
- By:
- Publication type:
- Article
Dermoscopic Findings in Cutaneous Metastases.
- Published in:
- JAMA Dermatology, 2014, v. 150, n. 4, p. 429, doi. 10.1001/jamadermatol.2013.8502
- By:
- Publication type:
- Article
Tracking of Second Primary Melanomas in Vemurafenib-Treated Patients.
- Published in:
- JAMA Dermatology, 2013, v. 149, n. 4, p. 488, doi. 10.1001/jamadermatol.2013.21
- By:
- Publication type:
- Article
Oncodermatology: Advancing the Science and Care of Cancer Patients and Survivors.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails.
- Published in:
- American Journal of Clinical Dermatology, 2018, v. 19, n. 1, p. 31, doi. 10.1007/s40257-018-0384-3
- By:
- Publication type:
- Article
Malignancy Risk and Recurrence with Psoriasis and its Treatments: A Concise Update.
- Published in:
- American Journal of Clinical Dermatology, 2018, v. 19, n. 3, p. 363, doi. 10.1007/s40257-017-0337-2
- By:
- Publication type:
- Article
Impact of Dermatologic Adverse Events on Quality of Life in 283 Cancer Patients: A Questionnaire Study in a Dermatology Referral Clinic.
- Published in:
- American Journal of Clinical Dermatology, 2013, v. 14, n. 4, p. 327, doi. 10.1007/s40257-013-0021-0
- By:
- Publication type:
- Article
IL12/23 Blockade with Ustekinumab as a Treatment for Immune-Related Cutaneous Adverse Events.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 11, p. 1548, doi. 10.3390/ph16111548
- By:
- Publication type:
- Article
Diagnosis of blue nevus-like metastatic uveal melanoma confirmed by fluorescence in situ hybridization (FISH) for monosomy 3.
- Published in:
- Journal of Cutaneous Pathology, 2012, v. 39, n. 6, p. 621, doi. 10.1111/j.1600-0560.2012.01893.x
- By:
- Publication type:
- Article
KSHV/HHV8-associated primary cutaneous plasmablastic lymphoma in a patient with Castleman’s disease and Kaposi’s sarcoma.
- Published in:
- Journal of Cutaneous Pathology, 2006, v. 33, p. 46, doi. 10.1111/j.1600-0560.2006.00539.x
- By:
- Publication type:
- Article
Ossified soft tissue leiomyoma in a patient with sickle cell anemia.
- Published in:
- Journal of Cutaneous Pathology, 2005, v. 32, n. 10, p. 696, doi. 10.1111/j.0303-6987.2005.00435.x
- By:
- Publication type:
- Article
Eosinophilic Rash Secondary to Temsirolimus.
- Published in:
- 2009
- By:
- Publication type:
- Case Study
Dermatological Adverse Events from BRAF Inhibitors: A Growing Problem.
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 3, p. 249, doi. 10.1007/s11912-013-0308-6
- By:
- Publication type:
- Article
Skin adverse events of anti-cancer treatments: an examination of drug-adverse events associations.
- Published in:
- Australian Journal of Cancer Nursing, 2024, v. 25, n. 1, p. 65
- By:
- Publication type:
- Article
Pruritus related to trastuzumab and pertuzumab in HER2 + breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 203, n. 2, p. 271, doi. 10.1007/s10549-023-07143-3
- By:
- Publication type:
- Article
Phase 1/2 study of topical submicron particle paclitaxel for cutaneous metastases of breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 194, n. 1, p. 57, doi. 10.1007/s10549-022-06584-6
- By:
- Publication type:
- Article
A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 186, n. 1, p. 107, doi. 10.1007/s10549-020-06005-6
- By:
- Publication type:
- Article
Dermatologic adverse events related to the PI3Kα inhibitor alpelisib (BYL719) in patients with breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 183, n. 1, p. 227, doi. 10.1007/s10549-020-05726-y
- By:
- Publication type:
- Article
The effect of scalp cooling on CIA-related quality of life in breast cancer patients: a systematic review.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 2, p. 267, doi. 10.1007/s10549-019-05169-0
- By:
- Publication type:
- Article
Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 174, n. 1, p. 15, doi. 10.1007/s10549-018-4996-3
- By:
- Publication type:
- Article
The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus.
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 12, p. 1, doi. 10.1007/s00520-023-08116-4
- By:
- Publication type:
- Article
PRO-CTCAE reveals under-recognition of dermatologic symptom burden in hospitalized cancer patients.
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 6, p. 1, doi. 10.1007/s00520-023-07793-5
- By:
- Publication type:
- Article
Natural history of nasal vestibulitis associated with paclitaxel, docetaxel, and other chemotherapy agents: a Minnesota Cancer Clinical Trials Network (MNCCTN) study.
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 11, p. 6253, doi. 10.1007/s00520-021-06190-0
- By:
- Publication type:
- Article
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe dermatological toxicities from checkpoint inhibitors.
- Published in:
- Supportive Care in Cancer, 2020, v. 28, n. 12, p. 6119, doi. 10.1007/s00520-020-05706-4
- By:
- Publication type:
- Article
A survey of patient and physician acceptance of skin toxicities from anti-epidermal growth factor receptor therapies.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Nasal vestibulitis due to targeted therapies in cancer patients.
- Published in:
- Supportive Care in Cancer, 2015, v. 23, n. 8, p. 2391, doi. 10.1007/s00520-014-2580-x
- By:
- Publication type:
- Article
Supporting Virtual Dermatology Consultation in the Setting of COVID-19.
- Published in:
- Journal of Digital Imaging, 2021, v. 34, n. 2, p. 284, doi. 10.1007/s10278-021-00425-6
- By:
- Publication type:
- Article
Risk of hand-foot skin reaction with sorafenib: A systematic review and meta-analysis.
- Published in:
- Acta Oncologica, 2008, v. 47, n. 2, p. 176, doi. 10.1080/02841860701765675
- By:
- Publication type:
- Article
A Comparison of Type I Collagen, Fibronectin, and Vitronectin in Supporting Adhesion of Mechanically Strained Osteoblasts.
- Published in:
- Journal of Bone & Mineral Research, 2002, v. 17, n. 3, p. 481, doi. 10.1359/jbmr.2002.17.3.481
- By:
- Publication type:
- Article
Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 1, p. 127, doi. 10.1111/bjh.19462
- By:
- Publication type:
- Article
Outcomes after interruption of targeted therapy in patients with histiocytic neoplasms.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 3, p. 389, doi. 10.1111/bjh.18964
- By:
- Publication type:
- Article
Melanoma and non-melanoma skin cancers in hairy cell leukaemia: a Surveillance, Epidemiology and End Results population analysis and the 30-year experience at Memorial Sloan Kettering Cancer Center.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 1, p. 84, doi. 10.1111/bjh.13528
- By:
- Publication type:
- Article
Risk of rash in cancer patients treated with vandetanib: systematic review and meta-analysis.
- Published in:
- 2012
- By:
- Publication type:
- journal article
A randomized phase 2 trial of the efficacy and safety of a novel topical povidone-iodine formulation for Cancer therapy-associated Paronychia.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 6, p. 1247, doi. 10.1007/s10637-019-00825-0
- By:
- Publication type:
- Article
A phase 1b dose expansion study of the pan-class I PI3K inhibitor buparlisib (BKM120) plus carboplatin and paclitaxel in PTEN deficient tumors and with dose intensified carboplatin and paclitaxel.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 6, p. 742, doi. 10.1007/s10637-017-0445-0
- By:
- Publication type:
- Article